When Michael was 16, he developed acute myelogenous leukemia. Now a cancer survivor, he is a college student looking forward to “taking the artistic field by force.”
Memorial Sloan-Kettering Cancer Center's experts on the Pediatric Leukemia and Lymphoma Service diagnose and treat children, adolescents, and young adults who have any form of leukemia, including acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML). Whether you come to us as soon as leukemia is suspected or after a relapse of leukemia treated elsewhere, we tailor our innovative treatments for each patient, based on the characteristics of your child and of his or her disease.
Our multidisciplinary team of experts has pioneered the use of new chemotherapy regimens that have increased long-term survival for children and young adults with leukemia. As a result, the outlook for young patients with leukemia has vastly improved over the past 30 to 40 years.
Today, the cure rate for ALL is close to 90 percent, and the cure rate for AML is more than 50 percent. We are continuing to participate in national clinical trials of emerging therapies that may benefit children even more.
Learn more about how we diagnose and treat pediatric leukemias.